BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4212971
Number of visits today
1087
Number of downloads
3847831
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Bryl E. B cells as target for immunotherapy in rheumatic diseases - current status. Immunol Lett 2021;236:12-9. [PMID: 34077805 DOI: 10.1016/j.imlet.2021.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bazzi SA, Maguire C, Holay N, Geltman J, Hurley K, DiPasquale C, Abigania M, Olson E, Ehrlich LIR, Triplett TA, Melamed E. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy. Mult Scler Relat Disord 2022;68:104195. [PMID: 36223705 DOI: 10.1016/j.msard.2022.104195] [Reference Citation Analysis]
2 Qin Y, Cai ML, Jin HZ, Huang W, Zhu C, Bozec A, Huang J, Chen Z. Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways. Ann Rheum Dis 2022:annrheumdis-2022-222605. [PMID: 35760450 DOI: 10.1136/ard-2022-222605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Co DO, Kwon JM. Autoimmune Encephalitis: Distinguishing Features and Specific Therapies. Critical Care Clinics 2022;38:393-412. [DOI: 10.1016/j.ccc.2021.11.007] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345